Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a minor update to the study record. This update does not alter the underlying study data or claims.
    Difference
    0.0%
    Check dated 2026-08-08T23:08:17.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Related topics section entries were removed: 'Multiple myeloma' and 'MedlinePlus Genetics', and the 'related topics' label was deleted. This changes how users access condition-specific information and external resources from the study page.
    Difference
    0.1%
    Check dated 2026-08-01T20:04:01.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating a template/update of the page framework without changes to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T16:52:00.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Added disease-related topics to the page (including 'Multiple myeloma' and a 'related topics' entry for 'MedlinePlus Genetics'). The site revision tag was updated from v3.6.2 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-04T08:30:56.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.6.0 to v3.6.2. This reflects a newer release of the page framework rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-06-27T03:21:19.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Multiple entries in the Study Documents section were deleted, removing access to key documents such as the Statistical Analysis Plan, Study Protocol, Informed Consent Form, IPD Sharing information, and related materials. This change reduces the transparency and accessibility of essential trial documentation for reviewers and participants.
    Difference
    20%
    Check dated 2026-06-19T23:46:49.000Z thumbnail image

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.